Literature DB >> 14520483

The role of inflammation markers in triggering acute coronary events.

Mehmet Tokaç1, Ali Ozeren, Murad Aktan, Bülent B Altunkeser, Kurtuluş Ozdemir, Akif Düzenli, Hasan Gök.   

Abstract

Studies have shown disparate results in relation to the role of plasma concentrations of inflammation markers such as fibrinogen, cytokines, and cell adhesion molecules in acute coronary syndromes. The differentiation of primary versus secondary alterations of these markers in response to acute coronary syndromes is not clear. The aim of this study was to investigate the effect of soluble cell adhesion molecules and some inflammatory markers on coronary plaque instability. The prospective study consisted of 15 patients with stable angina pectoris (SAP), 16 with unstable angina pectoris (UAP), and 16 who had undergone percutaneous transluminal coronary angioplasty (PTCA). Blood samples were obtained from the SAP group on admission, from the UAP group at the early stage of pain onset within 6 h of pain, and again after 12 h of pain. Samples from the PTCA group were collected before, 2, 14 h after the procedure. Soluble vascular cell adhesion molecule-1 (VCAM-1), endothelial selectin, interleukin-1 beta (IL-1 beta) and interleukin-2 (IL-2), and C-reactive protein (CRP) were analyzed by enzyme-linked immunosorbent assay. CRP serum levels gradually increased although IL-2 gradually decreased in patients with UAP and PTCA. In addition, VCAM-1 levels were sharply decreased after the PTCA procedure. However, this value returned back to the preprocedure levels 14 h after PTCA. Both CRP and IL-2 are directly involved in the triggering mechanisms of acute coronary events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520483     DOI: 10.1007/s00380-003-0708-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  9 in total

1.  Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.

Authors:  Satoshi Yoshino; Shuichi Hamasaki; Sanemasa Ishida; Tetsuro Kataoka; Akiko Yoshikawa; Naoya Oketani; Keishi Saihara; Hitoshi Ichiki; So Kuwahata; Shoji Fujita; Takuro Takumi; Issei Yoshimoto; Mitsuhiro Nakazaki; Chuwa Tei
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

2.  Effects of the shape of coronary arteries on the presence, extent, and severity of their disease.

Authors:  Recep Demirbag; Remzi Yilmaz
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

3.  Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.

Authors:  Josef Veselka; Sárka Procházková; Radka Duchonová; Ingrid Homolová; David Tesar; Kevin A Bybee
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

4.  Effects of verapamil and nifedipine on different parameters in lipopolysaccharide-induced septic shock.

Authors:  Basar Sirmagul; Fatma Sultan Kilic; Ozgül Tunc; Engin Yildirim; Kevser Erol
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

5.  Inflammatory markers in a 2-year follow-up of coronary artery disease.

Authors:  Katarzyna Mizia-Stec; Zbigniew Gasior; Barbara Zahorska-Markiewicz; Michał Holecki; Paweł Kumor
Journal:  Heart Vessels       Date:  2006-09-29       Impact factor: 2.037

6.  Effects of atorvastatin on inflammation and oxidative stress.

Authors:  Masaya Sugiyama; Masuo Ohashi; Hiroyuki Takase; Koichi Sato; Ryuzo Ueda; Yasuaki Dohi
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

7.  Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

Authors:  M Ragab; H Hassan; T Zaytoun; W Refai; B Rocks; M Elsammak
Journal:  Exp Clin Cardiol       Date:  2005

8.  Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion.

Authors:  Shunji Onimaru; Kazuo Nakamura; Hiroko Kariyazono; Ryuji Ikeda; Takayuki Ueno; Yoshihiro Fukumoto; Akira Yabuki; Ryuzo Sakata; Katsushi Yamada
Journal:  Heart Vessels       Date:  2006-03       Impact factor: 2.037

9.  Asymptomatic kindred of patients with coronary events have increased peripheral T-cell activities.

Authors:  Alper Sonmez; Ucler Kisa; Gokhan Uckaya; Tayfun Eyileten; Can Kinalp; M Ilker Yilmaz; Teoman Dogru; Mustafa Turan; I Hakki Kocar
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 1.814

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.